Insulin aspart 30, biphasic

insulin aspart 30 · Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Insulin aspart 30, biphasic, covering 2015-12-01 to 2018-11-14. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of Exenatide vs. Biphasic Insulin Aspart 30 on Glucose Variability in Type 2 Diabetes [Phase 4]